Pacific Edge narrows FY loss by 13% on 7% lift in revenue

Pacific Edge narrows FY loss by 13% on 7% lift in revenue
Rebecca Howard
By Rebecca Howard May 29 (BusinessDesk) - Pacific Edge narrowed its full-year loss by 13 percent on improving revenue as more urologists and healthcare organizations adopt its Cxbladder cancer diagnostics tests.  The Dunedin-based company reported a loss of $19.7 million in the year to March 31 or 4.5 cents per share versus a loss of $22.6 million in the prior year or 5.7 cents per share after the prior year was restated in line with the NZ IFRS 15 revenue accounting standards. This means that Pacific Edge now only recognizes revenue for...